Skip to main content
logo
Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.810
0.00 (0.00%)
At close: Sep 17, 2026, 4:00 PM EDT
1.805
-0.005 (-0.27%)
After-hours: Sep 17, 2026, 4:57 PM EDT

Kairos Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.81-5.45-2.6-1.81-1.05-2.15
Depreciation & Amortization
0.140.160.160.160.160.1
Other Amortization
--0.150.060.410.14
Stock-Based Compensation
0.850.480.22--0.3
Other Operating Activities
1.312.170.10.91--
Change in Accounts Payable
-0.41-0.790.40.770.131.19
Change in Other Net Operating Assets
-0.05-0.01-2.39-0.01--
Operating Cash Flow
-3.97-3.44-3.960.08-0.35-0.41
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Acquisitions
------0.11
Investing Cash Flow
------0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.14---
Long-Term Debt Issued
-3.6--0.930.35
Total Debt Issued
3.383.60.14-0.930.35
Short-Term Debt Repaid
---0.14--0.04-0.02
Total Debt Repaid
---0.14--0.04-0.02
Net Debt Issued (Repaid)
3.383.6--0.890.33
Issuance of Common Stock
--5.52--0.25
Other Financing Activities
0.183.06-0.39-0.43-0.17-
Financing Cash Flow
3.566.665.13-0.430.720.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.413.221.18-0.340.360.06

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-1.89-1.63-5.350.760.010.47
Unlevered Free Cash Flow
-1.89-1.63-5.380.77-0.120.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0---
Change in Working Capital
-0.46-0.81-1.980.760.131.19
SEC Filings: 10-K · 10-Q